cd T cells are non-conventional, innate-like T cells, characterized by a restricted T-cell receptor repertoire. They participate in protective immunity responses against extracellular and intracellular pathogens, tumour surveillance, modulation of innate and adaptive immune responses, tissue healing, epithelial cell maintenance and regulation of physiological organ function. In this study, we investigated the role of neutrophils during the activation of human blood cd T cells through CD3 molecules. We found that the up-regulation of CD69 expression, and the production of interferon-c and tumour necrosis factor-a induced by anti-CD3 antibodies was potentiated by neutrophils. We found that inhibition of caspase-1 and neutralization of interleukin-18 did not affect neutrophil-mediated modulation. By contrast, the treatment with serine protease inhibitors prevented the potentiation of cd T-cell activation induced by neutrophils. Moreover, the addition of elastase to cd T-cell culture increased their stimulation, and the treatment of neutrophils with elastase inhibitor prevented the effect of neutrophils on cd T-cell activation. Furthermore, we demonstrated that the effect of elastase on cd T cells was mediated through the protease-activated receptor, PAR1, because the inhibition of this receptor with a specific antagonist, RWJ56110, abrogated the effect of neutrophils on cd T-cell activation.
Introduction
cd T cells are non-conventional, innate-like T cells, characterized by a restricted T-cell receptor (TCR) repertoire. cd T cells recognize self and non-self molecules in a non-MHC-restricted manner. 1 They exert a variety of functions, which include protective immunity against extracellular and intracellular pathogens, tumour surveillance, modulation of innate and adaptive immune responses, tissue healing and epithelial cell maintenance, and regulation of physiological organ function. 2, 3 Vc9Vd2 T cells represent the major cd T-cell subset in human peripheral blood where they comprise 1-10% in healthy adults. Vc9Vd2 T cells acquire a pre-activated phenotype early in their development, allowing the rapid induction of a wide variety of functions following the detection of activating signals. 4, 5 Among them, they can exert a high cytotoxic response against infected and transformed cells, produce cytokines and chemokines, regulate the recruitment and activation of neutrophils, induce T helper type 1 polarization, and promote the activation of B cells and the presentation of antigenic peptides to T cells. [6] [7] [8] [9] Neutrophils are the most abundant leukocytes in human peripheral blood. 10 They are innate immune cells that play a key role in immunity against extracellular pathogens.
11 At infected tissues, neutrophils represent the first immune cells recruited by the local production of chemokines such as CXCL8. Neutrophils act as phagocytic cells, and they can destroy microbes through the action of oxidative and non-oxidative pathways such as lytic enzymes and antimicrobial peptides, and by the production of reactive oxygen species (ROS). [11] [12] [13] Serine
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proteases participate in the non-oxidative pathway of intracellular and extracellular pathogen destruction: namely elastase, proteinase 3 and cathepsin G. In addition to the role of serine proteases in pathogen destruction, they are involved in the regulation of pro-inflammatory responses and in a variety of chronic inflammatory diseases, such as chronic obstructive pulmonary disease, cystic fibrosis, acute lung injury and acute respiratory distress syndrome. [14] [15] [16] At inflammatory sites, neutrophil serine proteases are secreted into the extracellular milieu in response to inflammatory signals such as tumour necrosis factor (TNF-a), CXCL8 and lipopolysaccharide, among others. 17 A fraction of the released proteases remain bound in an active form on the external surface of the plasma membrane. The soluble and membranebound proteases can proteolytically regulate the activities of different chemokines, cytokines, growth factors, and cell surface receptors. 18, 19 Neutrophil serine proteases can cleave the N-terminal extracellular domain of proteaseactivated receptors (PARs), revealing a tethered ligand that allows the autoactivation of the receptor. 20 PARs are ubiquitously expressed in various tissues and cells, [21] [22] [23] [24] and they are a subfamily of related G-protein-coupled receptors.
It has been reported that neutrophils can modulate the activation of conventional T cells (TCR-ab), [25] [26] [27] [28] and we recently demonstrated that neutrophils also regulate the activation of cd T cells induced by the phosphoantigen HMBPP [(E)-1-hydroxy-2-methyl-but-2-enyl 4-diphosphate]. 29 In this study, we analysed whether neutrophils were able to modulate the phenotype and function of human blood cd T cells activated through CD3 molecules. Our data demonstrate that, under these conditions, neutrophils potentiate the activation of cd T cells, and this effect was mediated through the action of neutrophil elastase on the protease-activated receptor, PAR1.
Materials and methods

Reagents and antibodies
Ficoll-Hypaque and dextran were obtained from GE Healthcare Bio-Sciences AB (Uppsala, Sweden). Anti-TCR-cd MicroBead kit was obtained from Miltenyi Biotec (Bergisch Gladbach, Germany). RPMI-1640 medium, fetal bovine serum (FBS) and dihydrorhodamine 123 (DHR) were from Invitrogen (Carlsbad, CA). Anti-CD3 monoclonal antibodies (UTCH-1) were obtained from Beckman Coulter (Marseille, France). Phycoerythrin (PE)-conjugated mouse anti-CD11b, PE-Cy5-conjugated mouse anti-CD69 and isotype controls were from BD Biosciences (San Jose, CA). PE-conjugated anti-PAR1 monoclonal antibodies (ATAP2) and PAR1 antagonist RWJ56110 were from Santa Cruz Biotechnology (Dallas, TX). Rabbit anti-human elastase antibody was from Calbiochem (Massachusetts, MA), DyLight 549-conjugated goat anti-rabbit IgG and isotype-matched antibodies were purchased from Jackson Immunoresearch Laboratories (West Grove, PA). Mouse anti-human CD107a-PE was from BioLegend (San Diego, CA). Human interferon-c (IFN-c) and tumour necrosis factora (TNF-a) ELISA kit was from BD Bioscience (San Diego, CA). Human interleukin-18 (IL-18) detection antibodies, and blocking IL-18 antibodies (clone: 125-2H) were from MBL (Woburn, MA). Penicillin, streptomycin, elastase, elastase inhibitor MeOSuc-Ala-Ala-Pro-Val chloromethyl ketone (MeOSu-AAPV-CMK), granulocyte elastase substrate (Glp-Pro-Val-pNA), Fluoromount G and monensin, were purchased from Sigma-Aldrich (St Louis, MO). Ac-Tyr-Val-Ala-Asp-AOM (YVAD-CMK) caspase-1 inhibitor IV and AEBSF (Pefabloc-SC) were purchased from Calbiochem (Schaffhausen, Switzerland). X-Vivo15 medium was purchased from Lonza (K€ oln, Germany). Cathepsin G and proteinase 3 were from Athens Research and Technology (Athens, GA). Human a thrombin was from Enzyme Research Laboratories (South Bend, IN). HMBPP was obtained from Cayman Chemical (Ann Arbor, MI).
cd T-cell purification and culture
Peripheral blood samples were obtained from healthy donor volunteers after institutional Ethics Committee approval. Donors provided written informed consent before the collection of the samples. Peripheral blood mononuclear cells were isolated by standard density gradient centrifugation on Ficoll-Hypaque. Then, cd T cells were purified by using magnetic cell sorting with the anti-TCR-cd MicroBead isolation kit, according to the manufacturer's recommendations. The purity of recovered cells was > 98% in all the experiments as measured by flow cytometry. Cells were suspended in RPMI-1640 medium supplemented with 10% heat-inactivated FBS, penicillin (100 U/ml) and streptomycin (100 lg/ml).
Neutrophil purification and culture
Neutrophils were isolated from heparinized human blood samples by Ficoll-Hypaque gradient centrifugation and dextran sedimentation. Contaminating erythrocytes were removed by hypotonic lysis. After washing, cell pellets were suspended in RPMI-1640 medium supplemented with 10% heat-inactivated FBS, penicillin (100 U/ml) and streptomycin (100 lg/ml). The purity was checked by flow cytometry (> 98%).
Immunostaining and flow cytometry cd T cells were stained with PE-Cy5-conjugated antibodies directed to CD69 or PE-conjugated anti-PAR1. In all cases, isotype-matched control antibodies were used, and a gate based on size was defined in the analysis to exclude neutrophils. Neutrophil activation was evaluated by using a PE-conjugated antibody directed to CD11b. A gate based on size was done in the analysis to exclude cd T cells. In all cases, analysis was performed using a FACSCalibur flow cytometer and CELLQUEST software (BD Biosciences).
Detection of cytokines by ELISA
cd T cells (1 9 10 6 /ml) were stimulated or not with anti-CD3 antibodies (250 ng/ml, 30 min at 37°). Then, cells were cultured with or without neutrophils at a cell-to-cell ratio of 1 : 1. After 24 hr of culture, supernatants were harvested and the presence of IFN-c, TNF-a and IL-18 was analysed by ELISA, according to the manufacturer's recommendations.
Elastase measurement
The elastase activity was determined by spectrophotometry from their ability to cleave a specific substrate. Briefly, neutrophils (1 9 10 6 /ml) were cultured with or without cd T cells at a cell-to-cell ratio of 1 : 1. After incubation, supernatants were recovered and incubated with elastase substrate, Glp-Pro-Val-pNA (1 nM) during 24 hr at 37°. Elastase concentration was determined by reading changes in optical density at dual wavelength 405-550 nm by spectrophotometry (Biochrom Asys UVM 340 Microplate Reader, Holliston, MA) and by interpolation in a standard elastase concentration curve.
Transwell co-culture cd T cells (1 9 10 6 /ml) were stimulated with anti-CD3 antibodies (250 ng/ml, 30 min at 37°) immobilized on the lower chamber of a 96-transwell plate with a polycarbonate filter of 0Á4-lm pore size (Corning, Costar, USA). Afterward, neutrophils were added in the upper chamber at a cd T-cell : neutrophil ratio of 1 : 1. After 24 hr of culture at 37°, supernatants were recovered and the presence of IFN-c and TNF-a was analysed by ELISA, according to the manufacturer's recommendations.
Analysis of cell conjugates
Anti-CD3 antibodies (250 ng/ml) were immobilized on poly-L-lysine-coated glass coverslips (12 mm) (overnight at 37°), after which the coverslips were washed with PBS, and cd T cells were seeded and incubated at 37°in 5% CO 2 for 60 min. Then, neutrophils were added on a coverslip at a cell-to-cell ratio of 1 : 1, and incubated for 2 hr at 37°. After incubation, the coverslips were carefully washed with PBS and cells were fixed in 2% paraformaldehyde and stained for elastase. Briefly, after fixation the samples were permeabilized with 0Á5% Triton X-100 in PBS for 1 min and blocked with 5% goat serum for 60 min at 37°. Then samples were incubated with a rabbit anti-human elastase antibody (1 lg/ml) or the corresponding isotype controls for 45 min at 4°. After that, cells were washed with PBS with 0Á25% bovine serum albumin and incubated with a DyLight549-goat anti-rabbit IgG antibody (9 lg/ml) for 30 min at 4°. After washing, coverslips were mounted onto glass slides using Fluoromount-G solution. Immunofluorescence images were acquired with a FluoView FV1000 confocal microscope (Olympus, Tokyo, Japan) using a Plapon 60 9 1Á42 NA oil immersion objective. Images were analysed using the Olympus FV10-ASW and FIJI software (National Institutes of Health, Bethesda, MD).
Measurement of ROS production
Neutrophils were suspended in culture medium and incubated with 0Á1 lg/ml DHR for 5 min at 37°. Then, they were cultured with cd T cells previously stimulated with HMBPP (10 lM, 90 min) or with anti-CD3 antibodies (500 ng/ml, 5 hr) at a cell-to-cell ratio of 1 : 1. After 20 min at 37°, cells were analysed by flow cytometry by analysing the variation of the mean fluorescence intensity emission of DHR. A gate based on size was performed in the analysis to exclude cd T cells.
CD107a expression
cd T cells were stimulated with HMBPP (10 lM) or anti-CD3 antibodies (500 ng/ml) for 1 hr, then were cultured in the presence of PE-conjugated anti-CD107a antibodies and monensin (2 lM) for 5 hr at 37°. After that, cells were washed and analysed by flow cytometry. A gate based on size was carried out in the analysis to exclude neutrophils. As positive control, cd T cells were incubated with PMA (50 ng/ml) and ionomycin (5 lg/ml). Results are expressed as the percentage of positive cells for CD107a.
Statistical analysis
Student's paired t-test was used to determine the significance of differences between treatment groups. Multiple analyses were followed by Kruskal-Wallis's and Friedman's multiple-comparison post-test. The p-values < 0Á05 were considered statistically significant.
Results
Neutrophils potentiate the activation of cd T cells
Ex vivo manipulation and expansion of cd T cells are key steps for successful adoptive transfer immunotherapies.
Protocols have been developed for large-scale expansion of cd T cells ex vivo, using immobilized anti-CD3 antibodies. 30, 31 cd T cells generated under these conditions must be tested for their immune capacity and for their effector function profiles. Taking this into account, we decided to evaluate the phenotype and function of cd T (e) and TNF-a (n = 11) (f) by cd T cells were analysed. The data represent the mean AE SEM. *P < 0Á05 versus stimulated cd T cells in the absence of neutrophils (Ne), Friedman test for multiple comparisons with Dunn's post-test. Additionally, the expression of CD11b by neutrophils was analysed by flow cytometry (g) and the release of elastase was quantified in cell supernatants by using the granulocyte elastase substrate (Glp-Pro-Val-pNA) and spectrophotometry analysis (h). The data represent the mean AE SEM, n = 4 (CD11b) and n = 6 (elastase). *P < 0Á05, Mann-Whitney one-tailed test.
ª 2017 John Wiley & Sons Ltd, Immunology, 153, 225-237 Figure 2 . Soluble factors are involved during the activation of cd T cells by neutrophils. (a, b) cd T cells were stimulated with anti-CD3 antibodies (250 ng/ml) previously immobilized on the lower compartment of a 0Á4-lm pore size membrane transwell system. After 30 min, neutrophils were seeded (+Ne) or not (ÀNe) in the upper chamber at a cd T-cell : neutrophil ratio of 1 : 1. After 24 hr the production of interferon-c (IFN-c) and tumour necrosis factor-a (TNF-a) was analysed by ELISA. Data are shown as mean AE SEM, n = 4. *P < 0Á05, Mann-Whitney two-tailed test. (c-i) cd T cells were incubated for 30 min on 96-well flat-bottom culture plates, previously coated with anti-CD3 antibodies (250 ng/ml). Then, neutrophils were added at a cell-to-cell ratio of 1 : 1, and incubated for 24 hr. (c) After incubation, supernatants were recovered and IL-18 was measured by ELISA. The data represent the mean AE SEM, n = 4. *P < 0Á05 versus stimulated cd T cells in absence of Ne, Kruskal-Wallis test for multiple comparisons with Dunn's post-test. (d-f) Neutrophils were pre-incubated with caspase-1 inhibitor, YVAD-CMK (YVAD, 20 lM, 30 min at 37°), then were added to cd T-cell culture, the inhibitor was present during the whole incubation time. After 24 hr of incubation, the expression of CD69 (n = 7) (d), and the production of IFN-c (n = 5) (e) and TNF-a (n = 3) (f) by cd T cells were analysed. The data represent the mean AE SEM. *P < 0Á05 versus stimulated cd T cells in absence of Ne, Friedman test for multiple comparisons with Dunn's post-test. (g-i) Neutrophils were preincubated with the irreversible serine proteases inhibitor, Pefabloc-SC (PF, 20 lg/ml, 30 min at 37°). The inhibitor was present during the whole incubation time. The expression of CD69 (n = 13) (g), and the production of IFN-c (n = 7) (h) and TNF-a (n = 4) (i) by cd T cells were analysed. The data represent the mean AE SEM. cells activated by anti-CD3 antibodies and their interaction with neutrophils. For this purpose, freshly purified human cd T cells were stimulated with immobilized anti-CD3 antibodies for 24 hr. Then, we analysed the expression of CD69 and the cytokine production. As expected, CD3 stimulation increased the expression of CD69 ( Fig. 1a) and the production of the inflammatory cytokines IFN-c (Fig. 1b) and TNF-a (Fig. 1c) . To determine whether neutrophils were able to regulate the activation of cd T cells, both cell types were co-cultured for 24 hr at a cell-to-cell ratio of 1 : 1, according to previous settings established by our group. 29 In co-cultures, the viability of cd T cells was not altered by incubating cells with neutrophils, as revealed by propidium iodide staining and flow cytometry analysis (data not shown). We observed that neutrophils potentiated the up-regulation of CD69 expression in cd T cells (Fig. 1d) and the production of IFN-c (Fig. 1e ) and TNF-a (Fig. 1f) . Of note, the production of these cytokines by neutrophils cultured alone was negligible (data not shown). Similarly to the effect we reported by employing HMBPP, 29 we found that cd T cells activated by anti-CD3 antibodies also induced neutrophil activation as indicated by the up-regulation of CD11b and the release of elastase to the extracellular medium by neutrophils (Fig. 1g,h ).
Soluble factors released by neutrophils regulate the activation of cd T cells
We then speculated that soluble factors released by neutrophils activated by the co-culture with stimulated cd T cells might be responsible for the increase in cd T-cell activation. First, we performed experiments using 96-transwell chambers with a polycarbonate filter (0Á4-lm pore size). For this purpose, cd T cells were included in the lower chamber of the transwell system previously coated with anti-CD3 antibodies, whereas neutrophils were seeded in the upper chamber at a cd T-cell : neutrophil ratio of 1 : 1. We observed that neutrophils enhanced the activation of cd T cells even when both cell types were placed in different chambers of the transwell system, indicating that potentiation involves the participation of soluble factors released by neutrophils (Fig. 2a,b) . Hence, to gain insight into the neutrophil molecules involved in the activation of cd T cells, we searched for factors secreted by activated neutrophils, which could play a role in the activation of T cells. Among these molecules, IL-18 is an inflammatory cytokine produced by neutrophils in response to stimulation by TNF-a 32 that promotes both the proliferation of CD8 + T cells stimulated by anti-CD3 antibodies, 33 and the expansion of natural killer cells in the presence of IL-2. 34 Moreover, it was reported that IL-18 stimulates the proliferation of cd T cells activated by IL-2 and zoledronate, and the blockade of the IL-18Ra chain strongly inhibits the proliferation of cd T cells, suggesting the involvement of IL-18 signalling. 35 Then, we decided to determine whether IL-18 was responsible for neutrophil enhancement of cd T-cell activation induced by anti-CD3 stimulation. However, we detected low levels of IL-18 in supernatants obtained from co-cultures of cd T cells and neutrophils in the presence of anti-CD3 antibodies (Fig. 2c) . Because we could not exclude the possibility that IL-18 produced by neutrophils could act on cd T cells even if it was produced at low concentrations, we performed experiments using a specific inhibitor of caspase-1, YVAD-CMK, to inhibit the maturation of pro-IL-18 to IL-18. Co-culture of cd T cells and neutrophils in the presence of YVAD-CMK did not abrogate the increase in cd T-cell activation induced by neutrophils as measured by CD69 expression and IFN-c and TNF-a production ( Fig. 2d-f ). YVAD-CMK was able to inhibit neutrophil IL-1b secretion, another cytokine which relies on caspase-1 to generate its mature form 36 (see Supplementary material, Fig. S1 ). We also performed blocking experiments by adding neutralizing antibodies anti-IL-18 to neutrophil-cd T-cell co-cultures, and we observed that this treatment did not inhibit cd T-cell stimulation induced by neutrophils (see Supplementary material, Fig. S2a-c) , confirming that IL-18 does not play a role in the potentiation of cd T-cell activation induced by neutrophils. It has also been reported that neutrophil proteases could regulate cd T-cell function. 37 As we determined that upon co-culture with activated cd T cells, neutrophils release elastase (Fig. 1h) , we speculated that this serine protease could modulate cd T-cell function. To test this hypothesis we used the irreversible inhibitor of serine proteases AEBSF (Pefabloc-SC). This compound abrogated the increase in cd T-cell activation induced by neutrophils (Fig. 2g-i) . In line with these findings, elastase added to cd T-cell cultures in the absence of neutrophils, reproduced the increase in the production of IFN-c (Fig. 3a) and TNF-a (Fig. 3b) observed in co-cultures of cd T cells and neutrophils. A similar effect was observed in cells treated with cathepsin G and proteinase 3 (see Supplementary material, Fig. S3a-c) . Furthermore, when we pre-incubated elastase with its specific inhibitor MeOSu-AAPV-CMK, the effect of this serine protease was reversed, demonstrating that its action on cd T cells relies on the enzymatic activity (Fig. 3c) . We hypothesize that polarized release of elastase from neutrophils to cd T cells would potentiate cd T-cell function, and to evaluate this, we performed fluorescence microscopy studies. Interestingly, the results showed that neutrophils actually interact with cd T cells (Fig. 3d) , and a quantitative analysis revealed that when cultured together for 2 hr at 37°, 32 AE 1% of neutrophils formed cell conjugates with cd T cells (mean AE SEM, n = 2). Among conjugates, 69 AE 1% of them expressed elastase in the interface between cd T cells and neutrophils (Fig. 3e) . Moreover, the fluorescence intensity was higher at the site of cell contact (Fig. 3f,g ). Additionally, when we performed co-culture of cd T cells with neutrophils in the presence of elastase inhibitor, we reversed completely the potentiation of CD69 expression on cd T cells (Fig. 3h) , and partially the effect on cytokine production (Fig. 3i,j) . This partial reduction observed on cytokine secretion could be a result of low concentrations of elastase inhibitor having to be used because at higher concentrations this inhibitor exhibited off-target effects on cd T cells themselves (data not shown).
PAR1 modulates cd T-cell activation induced by CD3 stimulation
In different cell types, serine proteases induce cell activation by acting on PARs. These receptors are G-proteincoupled receptors expressed on the cell surface, and are activated by irreversible proteolytic cleavage, leading to the exposure of a cryptic N-terminal sequence, which serves as a tethered ligand. The newly exposed tethered ligand then activates the receptor, 20 and this self-activation prompts the conformational change of the receptor that allows interactions with G proteins. 38 In humans, there are four PARs described to date: PAR1, PAR2, PAR3 and PAR4, which are expressed by different cell types including circulating blood cells. [21] [22] [23] [24] Recently it was reported that cd T cells only express PAR1. 39 As this receptor is activated by elastase among other proteases, we decided to evaluate the role of PAR1 during cd T-cell stimulation by neutrophils. First, we analysed the expression of this receptor on purified cd T cells employing B cells as a negative control. As shown in Fig. 4(a-c) , cd T cells express PAR1. This receptor was functional as we could activate it using thrombin, a specific agonist. Thrombin treatment increased CD69 expression (Fig. 4d ) and cytokine production (Fig. 4e,f) by cd T cells. Then, we decided to examine the effect of blocking PAR1 with the specific antagonist RWJ56110. For this purpose, cd T cells were pretreated with this compound and then stimulated with anti-CD3 in the presence or absence of neutrophils. As shown in Fig. 4(g-i) , RWJ56110 reverted the potentiation of cd T-cell activation induced by neutrophils, as measured through the expression of CD69 (Fig. 4g) , and the production of IFN-c (Fig. 4h ) and TNF-a (Fig. 4i ).
Elastase and ROS during cd T-cell activation
We have been previously reported 29 that neutrophils inhibited the activation of cd T cells induced by HMBPP by a mechanism dependent on the production of ROS. To study the contrasting effects exerted by neutrophils on HMBPP and anti-CD3-stimulated cd T cells, we decided to analyse the release of elastase by neutrophils co-cultured with cd T cells activated by HMBPP, as well as the production of ROS when neutrophils were co-cultured with cd T cells activated with anti-CD3 antibodies. Figure 5(a) shows that in the presence of cd T cells activated with HMBPP, neutrophils release elastase. Moreover, in the presence of the elastase inhibitor, the reduction mediated by neutrophils of cd T-cell activation induced by HMBPP was even higher compared with that observed in the absence of the inhibitor (Fig. 5b,c) . In line with these results, we observed that the addition of the serine proteases elastase, cathepsin G and proteinase 3 increased the activation of cd T cells induced by HMBPP (see Supplementary material, Fig. S4a,b) . These findings suggest that upon HMBPP activation, the inhibitory role of ROS and the enhancer effect of elastase co-exist, and when elastase is inhibited, ROS more efficiently suppress cd T-cell activation. On the other hand, in contrast to that observed when neutrophils are cultured with cd T cells activated by HMBPP, we did not detect ROS production when these cells were activated by anti-CD3 (Fig. 5d,e) . These results suggest that ROS are not involved in the regulation of cd T-cell activation by anti-CD3 antibodies. Interestingly, in additional assays, we observed that cd T cells activated through CD3 showed higher cytotoxic activity compared with cd T cells stimulated by HMBPP or control cells (Fig. 5f,g ), further supporting the idea that different stimuli can induce distinct profiles of activation.
Discussion
Neutrophils produce a broad array of molecules 11 that contribute to the modulation of the function of immune cells such as macrophages, dendritic cells, natural killer cells and T cells. 29, [40] [41] [42] [43] In this work, we show for the first time that freshly isolated neutrophils potentiate the activation of cd T cells stimulated through CD3. We observed that neutrophils increased the up-regulation of CD69 and the production of IFN-c and TNF-a by anti-CD3-stimulated cd T cells. IL-18 is a pro-inflammatory cytokine secreted by neutrophils, and it was reported that it can enhance the activation of T cells. 33, 35 However, our results showed that IL-18 is not involved in the potentiation of cd T-cell activation by neutrophils. A possible role for this cytokine was ruled out because inhibition of caspase-1, the enzyme that processes pro-IL-18 into IL-18, and blocking experiments using anti-IL-18 neutralizing antibodies did not impede the potentiation of cd T-cell activation by neutrophils. By contrast, an inhibitor of serine proteases was able to inhibit the increase in cd T-cell activation mediated by neutrophils; and the addition of exogenous elastase could reproduce neutrophil effects, suggesting that this enzyme released by neutrophils, upon co-culture with activated cd T cells, promotes further cd T-cell activation. Previous studies showed that neutrophil serine proteases can cleave the Nterminal extracellular domain of PARs. 38 We have demonstrated that cd T-cell stimulation by neutrophil elastase was mediated through PAR1, as inhibition of this receptor abrogated the potentiation of cd T-cell activation mediated by neutrophils. Our results are in accordance with those previously reported by Hurley et al., which showed that activation of PAR1 by thrombin in conventional T cells (TCR-ab), promotes antigen-dependent cytokine production and tissue inflammation. 44 Fazio et al. showed in neutrophil-free cd T-cell cultures that treatment of cells with serine proteases inhibits cd T-cell proliferation and effector functions induced by phosphoantigens. 37 Contrasting with these findings, we also observed a stimulatory effect of proteases on HMBPP-stimulated cd T cells. The reasons for this discrepancy remain uncertain, but may be related to differences in the experimental setting between both works. In fact, studies conducted by Fazio et al. used cd T cells amplified from peripheral mononuclear cells stimulated by zoledronate and IL-2, whereas we employed magnetic bead-purified cd T cells stimulated by the exogenous phosphoantigen HMBPP.
We previously reported that ROS play a major role in the down-modulation of cd T-cell activation induced by HMBPP. 29 In contrast to those findings, we showed here that when cd T cells are stimulated through CD3 the production of ROS was undetectable, and elastase activity was responsible for the modulation of T-cell function by neutrophils. These results suggest that different stimuli induce diverse activation states of cd T cells, which allow them to respond differentially to extracellular factors. In this regard, it has been reported that stimulation by anti-CD3 antibodies triggers conformational changes in the human Vc9Vd2 TCR. 45 Moreover, different anti-CD3 antibodies, such as UCHT1 and OKT3, promote differential responses on cd T cells, UCHT1 antibodies being more potent to prompt CD3 conformational changes than OKT3. 45 Furthermore, cd T cells not only display differences at the CD3 conformation, but also show differences in the intracellular signalling downstream of the TCR. Hence, triggering conformational changes in CD3 in the TCR-cd led to enhanced signalling events. 45 More interesting, Dopfer et al. reported that stimulation of cd T cells by the synthetic phosphoantigens, bromohydrin pyrophosphate or isopentenyl pyrophosphate does not induce the conformational changes in CD3, demonstrating differential behaviour of cd T cells when they are stimulated with different agonists. These findings could explain the dissimilarities in the degranulation capacity that we observed in cd T cells stimulated with HMBPP or with anti-CD3 antibodies. In Figure 5 . Elastase and reactive oxygen species as modulators during cd T-cell activation. cd T cells were stimulated with (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate (HMBPP) (10 lM, 60 min at 37°), then washed and culture with neutrophils at a cell-to-cell ratio of 1 : 1. After 24 hr, the release of elastase was quantified in cell supernatants by using the granulocyte elastase substrate (Glp-Pro-Val-pNA) and spectrophotometry analysis (a). The data represent the mean AE SEM, n = 9. **P < 0Á01, Wilcoxon two-tailed test. (b and c) Previously to being added to cd T cells culture, neutrophils were incubated with the elastase inhibitor (EI, 3 lM, 30 min at 37°). The inhibitor was present during the whole incubation time. The production of interferon-c (IFN-c) (b) and tumour necrosis factor-a (TNF-a) (c) by cd T cells were analysed. The data represent the mean AE SEM, n = 10. *P < 0Á05, **P < 0Á01 and ***P < 0Á001, Kruskal-Wallis test for multiple comparisons with Dunn's post-test. this regard, we observed that stimulation through CD3 promotes higher levels of degranulation than that induced by HMBPP as judged by an increased in CD107a expression on cd T cells.
It is important to consider that the activity of cd T cells against target cells depends, not only on the expression of cognate antigens, but also on the resulting balance among signals from co-stimulatory molecules, adhesion molecules and activating or inhibitory natural killer receptors. 46, 47 Hence, it is possible to speculate that depending on the resulting signal, cd T cells differentially interact with neutrophils, modulating ROS production levels, which would in turn shift the balance towards inhibition or up-regulation of cd T-cell activation. This could also explain the inhibitory effect of serine proteases reported by Fazio et al., on cd T-cell proliferation induced by particles coated with anti-CD2, anti-CD3 and anti-CD28 antibodies, 37 which constitute a multiple activator signal. Taken together, this set of circumstances allows us to propose that cd T cells could respond differentially to neutrophil regulation if they are activated by different stimuli, such as phosphoantigens or anti-CD3 antibodies, as we demonstrated in our present work. cd T-cell physiology is complex and its activation could have many levels of regulation.
Besides the role of serine proteases during innate immune responses, it was observed in different lung diseases that the initiation and propagation of lung damage is a consequence of an exaggerated inflammatory response, which includes the release of proteases and cytotoxic products by leukocytes. 16, 48 A balance between proteases and anti-proteases is required, and when proteases are not neutralized properly it results in lung damage. 49 To control exacerbated proteolysis at sites of inflammation, the administration of therapeutic inhibitors of proteases has been tested as a therapy for a variety of inflammatory and infectious lung diseases. 50 In pathologies such as chronic obstructive pulmonary disease, cd T cells are present in the inflamed tissue, and they are an important source of IL-17A, which is a cytokine that regulates lung immunity and inflammation. 51 Taking this into account, we speculate that the inhibition of serine proteases (i.e. elastase) would reduce not only their own effect but also the action of the enzyme on cd T cells, thereby limiting a harmful immune response mediated by these T cells.
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